U.S. Market for Emerging At-Home Diagnostics

• 1.1 Scope and Objectives of Report
• 1.2 Methodology
• 1.3 Market Overview

2 Testing Sample Types

• 2.1 Blood Tests
• 2.2 Hair Tests
• 2.3 Saliva Tests
• 2.4 Urine Tests

3 Conditions Evaluated by Emerging At Home Tests

• 3.1 Cancer
• 3.1.1 Colon Cancer
• 3.1.2 Prostate Cancer
• 3.2 Coronary Artery Disease
• 3.3 Drug Abuse
• 3.3.1 Alcohol
• 3.3.2 Cocaine
• 3.3.3 Marijuana
• 3.3.4 Methamphetamines
• 3.3.5 Tobacco
• 3.4 HIV/AIDS
• 3.5 Hepatitis C
• 3.6 Infertility
• 3.7 Urinary Disorders
• 3.8 Hormone Levels
• 3.8.1 Male
• 3.8.2 Female
• 3.9 Osteoporosis
• 3.10 Thyroid Disorders

4 Emerging At-Home Test Products

• 4.1 Cholesterol Tests
• 4.1.1 Lifestream Technologies’s Personal Cholesterol Monitor
• 4.1.2 Polymer Technology Systems’s PTS Panels Lipid Panel Test
• 4.1.3 Biosafe Laboratories’s Cholesterol Panel
• 4.1.4 Home Access Health’s Home Access Instant Cholesterol Test
• 4.1.5 CholesTrak’s Cholesterol Test
• 4.1.6 Chemcard Cholesterol
• 4.1.7 Worldwide Medical’s First Check
• 4.2 Infectious Disease Tests
• 4.2.1 HIV/AIDS: Home Access Health’s Home Access HIV Test
• 4.2.2 Hepatitis C: Home Access Hepatitis C Test
• 4.2.3 Urinary Tract Infection
• 4.2.4 Vaginal Infection: FemTek’s pHEM-ALERT
• 4.3 Fecal Occult Blood Tests
• 4.3.1 Biomerica’s EZ Detect Stool Blood Test
• 4.4 Drug Tests
• 4.4.1 Alcohol
• 4.4.2 Cocaine, Marijuana, Methamphetamine, Opiates
• 4.4.3 Tobacco
• 4.5 Hormone Tests
• 4.5.1 Male Hormones: FertilMARQ/VasMARQ
• 4.5.2 Male and Female Hormones: SureStep Menopause Predictor Test
• 4.5.3 Thyroid Hormones: Biosafe Laboratories’s TSH Test
• 4.6 Miscellaneous/Other Tests
• 4.6.1 Prothrombin Time Test (PTT): Avocet Medical’s AcuSure System and International
• Technidyne’s Prothrombin Time Test System
• 4.6.2 Bladder Cancer: Matritech’s NMP22 BladderChek Test
• 4.6.3 Breast Cancer: Biomerica’s Aware Pad
• 4.6.4 Prostate Cancer: Biosafe’s PSA4 Test
• 4.6.5 Bone Mass: Ostex International’s Osteomark NTx POC

5 Research and Development

• 5.1 Alzheimer’s Disease Testing
• 5.2 Rheumatoid Arthritis Testing
• 5.3 Infectious Disease Testing
• 5.3.1 Strep Throat
• 5.3.2 Mononucleosis
• 5.3.3 Influenza
• 5.3.4 H. pylori (Gastric Ulcer)
• 5.3.5 Lyme Disease
• 5.4 Future Diagnostic Products
• 5.4.1 Cholesterol Testing
• 5.4.2 Infectious Disease Testing
• 5.4.3 Fecal Occult Blood Testing
• 5.4.4 Drug Testing

6 Market Issues and Trends

• 6.1 Clinical Laboratory Improvement Amendments (CLIA)
• 6.2 Concerns With Non-Approved Tests
• 6.3 Physician Concerns vs Consumer Demands
• 6.4 Medical Device Amendment

7 Market Revenues and Forecasts

• 7.1 Total Market Analysis
• 7.1.1 Market Analysis and Methodology Concerns
• 7.2 Cholesterol Testing Market
• 7.3 Infectious Disease Testing Market
• 7.4 Fecal Occult Blood Testing Market
• 7.5 Drug Testing Market
• 7.6 Hormone Testing Market
• 7.7 Miscellaneous/Other Testing Market

8 Competitive Analysis

• 8.1 Competitor Companies: Current Market Shares
• 8.2 Product Cost Analysis

9 Selected Company Profiles

• 9.1 AccuTech, LLC
• 9.2 Advantage Diagnostic Corp.
• 9.3 Beckman Coulter, Inc.
• 9.4 Biomerica, Inc.
• 9.5 Biosafe Medical Technologies, Inc.
• 9.6 Chematics, Inc.
• 9.7 Embryotech Laboratories, Inc.
• 9.8 Helena Laboratories Corp.
• 9.9 Home Access Health Corp.
• 9.10 International Technidyne Corp. (ITC)
• 9.11 Lifestream Technologies, Inc.
• 9.12 Ostex International, Inc.
• 9.13 Phamatech, Inc.
• 9.14 Polymer Technology Systems, Inc.
• 9.15 Princeton BioMeditech Corp.
• 9.16 Psychemedics Corp.
• 9.17 Roche Diagnostics Corp.
• 9.18 Sun Biomedical Laboratories, Inc.
• 9.19 Worldwide Medical Corp.

10 Company Directory